Oncology Impact Fund (Cayman) Management L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 165,530 shares at $34.68 ($5.6M) on 2021-12-03, disclosed to the SEC on 2021-12-07.
Open-market sale of $5.6M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.68 | 29,402 | $1.0M | 18.3% |
| 2 | $34.68 | 29,402 | $1.0M | 18.3% |
| 3 | $35.44 | 4,047 | $143K | 2.6% |
| 4 | $35.44 | 4,047 | $143K | 2.6% |
| 5 | $36.26 | 300 | $11K | 0.2% |
| 6 | $32.35 | 14,173 |
| $458K |
| 8.2% |
| 7 | $32.35 | 14,173 | $458K | 8.2% |
| 8 | $33.57 | 1,960 | $66K | 1.2% |
| 9 | $33.57 | 1,960 | $66K | 1.2% |
| 10 | $34.08 | 850 | $29K | 0.5% |
| 11 | $35.04 | 100 | $4K | 0.1% |
| 12 | $33.15 | 30,059 | $996K | 17.9% |
| 13 | $33.15 | 30,059 | $996K | 17.9% |
| 14 | $34.11 | 2,499 | $85K | 1.5% |
| 15 | $34.11 | 2,499 | $85K | 1.5% |
| Total | $33.72 avg | 165,530 | $5.6M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $8.7M | — | Filing → |